Linc AB Company Description

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies.

It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses.

The investments are made in both private and public companies and in research and operational companies.

The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.99 million), the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment.

Linc AB was founded in 1991 and based in Stockholm, Sweden.

Linc AB

Country	Sweden
Founded	1991
Industry	Asset Management
Sector	Financials
Employees	2
CEO	Karl Tobieson

Contact Details

Address: Vasagatan 28 Stockholm, 111 20 Sweden
Phone	46 709 35 85 74
Website	linc.se

Stock Details

Ticker Symbol	LINC
Exchange	Nasdaq Stockholm
Fiscal Year	January - December
Reporting Currency	SEK
ISIN Number	SE0015949433
SIC Code	6799

Key Executives

Name	Position
Karl Tobieson	Chief Executive Officer
Thomas Bergh	Chief Financial Officer